Background Image
Previous Page  155 / 182 Next Page
Information
Show Menu
Previous Page 155 / 182 Next Page
Page Background

154

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

18

BioDelivery Sciences International Inc. A double-blind placebo controlled evaluation of

the efficacy, safety and tolerability of BEMATM fentanyl in the treatment of breakt-

hrough pain in cancer subjects. Clinical study report FEN-201. Raleigh (NC): BioDelivery

Sciences International Inc., 2007 (data on file).

19

Borland M, Jacobs I, King B, O'Brien D. A randomized controlled trial comparing

intranasal fentanyl to intravenous morphine for managing acute pain in children in the

emergency department. Ann Emerg Med 2007; 49(3): 335-340.

20

Borland ML, Bergesio R, Pascoe EM, Turner S, Woodger S. Intranasal fentanyl is an

equivalent analgesic to oral morphine in paediatric burns patients for dressing changes:

a randomised double blind crossover study. Burns 2005; 31(7): 831-837.

21

Borland ML, Clark LJ, Esson A. Comparative review of the clinical use of intranasal

fentanyl versus morphine in a paediatric emergency department. Emerg Med Australas

2008; 20(6): 515-520.

22

Borland ML, Jacobs I, Geelhoed G. Intranasal fentanyl reduces acute pain in children

in the emergency department: a safety and efficacy study. Emerg Med 2002; 14(3):

275-280.

23

Boys L, Peat SJ, Janna MH, Burn K. Audit of neural blockade for palliative care patients

in an acute unit. Palliative Medicine 1993; 7: 205-211.

24

Bredenberg S, Duberg M, Lennernäs B, Lennernäs H, Pettersson A, Westerberg M,

Nyström C. In vitro and in vivo evaluation of a new sublingual tablet system for rapid

oromucosal absorption using fentanylcitrate as the active substance. Eur J Pharm Sci

2003; 20: 327-334.

25

Breivik H, Cherry N, Collet B, de Conno F, Filbet M, Foubert AJ, Cohen R, Dow L. Cancer-

related pain: a pan-European survey of  prevalence, treatment, and patient attitudes.

Ann Oncol 2009; 20: 1420-1433.

26

Brogan SE, Winter NB. Patient-controlled intrathecal analgesia for the management of

breakthrough cancer pain: a retrospective review and commentary. Pain Med 2011;

12(12): 1758-1768.

27

Bruera E, Fainsinger R, MacEachern T, Hanson J. The use of methylphenidate in patients

with incident cancer pain receiving regular opiates. A preliminary report. Pain 1992; 50:

75-77.

28

Bruera E, Neumann CM. Cancer pain. In: Sykes N, Fallon MT, Pratt RB (Hrsg.), Clinical

Pain Management (pp. 63-71). New York: Oxford University Press, 2003.

29

Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, Suarez-Almazor M.

A prospective multicenter assessment of the Edmonton Staging System for cancer pain.

Journal of Pain and Symptom Management 1995; 10: 348-355.

30

Bundesverfassungsgericht, Beschluss vom 11. August 1999, Neue Juristische Wochen-

schrift 1999 S 3399; Beschluss vom 6. Dezember 2005, Amtliche Sammlung BVerfGE

Bd. 115 S. 25 ff.; Beschluss vom 19. März 2009 - 1 BvR 316/09,

www.bverfg.de/ent-

scheidungen. Bundesverwaltungsgericht, Urteil vom 19. Mai 2005, Neue Juristische

Wochenschrift 2005 S 3300.

Literaturverzeichnis